Adicet Bio, Inc.
ACET· Nasdaq
Released Jul 30, 2020, before the open
10-Q filed Jul 30, 2020, 30 days after period end · 0001564590-20-034835
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$8.46M | -$2.65M | -$13.59M | -$4.06M |
| EPS Diluted | -$3.88 | -$0.51 | -$0.48 | -$0.94 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR